SCHEMBL28665720

SCHEMBL28665720

c1ccc(N2CCN(c3nc(-c4ccc5ccccc5c4)no3)CC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.54
▸ GAA P10253 1/20 0.54
▸ THRB P10828 1/20 0.54
▸ ALDH1A1 P00352 2/20 0.51
▸ TP53 P04637 2/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ LMNA P02545 3/20 0.47
▸ TSHR P16473 2/20 0.47
▸ NR1H4 Q96RI1 5/20 0.46
▸ SIGMAR1 Q99720 1/20 0.44
▸ HDAC4 P56524 1/20 0.44
▸ DRD3 P35462 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28688168 0.90 MAPT (0.53) MAPTGAATHRBALDH1A1TP53
SCHEMBL28681669 0.90 MAPT (0.56) MAPTGAATHRBALDH1A1TP53
SCHEMBL28930626 0.90 MAPT (0.68) MAPTGAATHRBALDH1A1TP53
SCHEMBL28667773 0.88 MAPT (0.62) MAPTGAATHRBALDH1A1TP53
SCHEMBL28667847 0.88 MAPT (0.56) MAPTGAATHRBALDH1A1TP53
SCHEMBL28680258 0.88 MAPT (0.53) MAPTGAATHRBALDH1A1TP53
SCHEMBL28665641 0.87 MAPT (0.58) MAPTGAATHRBALDH1A1TP53
SCHEMBL28665714 0.87 MAPT (0.64) MAPTGAATHRBALDH1A1TP53
SCHEMBL28661668 0.85 MAPT (0.51) MAPTGAATHRBALDH1A1TP53
SCHEMBL28676593 0.85 MAPT (0.53) MAPTGAATHRBALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108658889-B 1,2, 4-oxadiazole-aryl piperazine compound containing naphthalene ring and preparation method and application thereof 贵州医科大学 2021-12-17 — — CN disclosed
Send feedback